Gilead is US owned. But that's not the point. The question is why aren't we using both? HCQ could easily be mass distributed to low risk patients with moderate covid symptoms. Then we compare to how patients in Blue states are doing that banned the distribution of the drug.

Remdesivir probably does something but I wouldn't call reducing hospital stay by 4 days with a POTENTIAL effect on mortality a game changer.